Rury R. Holman
Indiana University Health(US)Australian Research Council(AU)Churchill Hospital(GB)John Radcliffe Hospital(GB)University of Oxford(GB)St. Mark's Hospital(US)Oxford Centre for Diabetes, Endocrinology and Metabolism(GB)Churchill Centre(US)Oxford BioMedica (United Kingdom)(GB)Indiana University – Purdue University Indianapolis(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Diabetes, Cardiovascular Risks, and Lipoproteins, Metabolism, Diabetes, and Cancer, Cardiovascular Function and Risk Factors
Most-Cited Works
- → 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes(2008)7,703 cited
- → Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy(2008)3,831 cited
- → Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy(2006)2,926 cited
- → Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes(2015)2,564 cited
- → Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes(2017)2,088 cited
- → Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)(1998)2,031 cited